Phospholipids are of critical importance in mammalian cell biology, both through providing a permeability barrier and acting as substrates for synthesis of lipid mediators. Recently, several new families of bioactive lipids were identified that form through the enzymatic oxidation of membrane phospholipids in circulating innate immune cells and platelets.
Introduction
During infection and injury, circulating innate immune cells and platelets respond acutely to a variety of pathophysiological agonists that mediate profound changes in both their function and physical state. Significant alterations in the lipid compartment, including changes to the plasma membrane and generation of potent signaling mediators occur within 2 -5 min of stimulation [1] [2] [3] [4] . Activation of neutrophils, monocytes and platelets leads to several common events at the plasma membrane, including shape change, flattening, adhesion, phagocytosis, microvilli and microparticle generation 5, 6 Phospholipids are the building blocks of the cell membrane, forming a permeability barrier and providing substrates for generation of important signaling mediators, including platelet-activating factor (PAF), phosphoinositides, diacylglycerides (DGs), sphingosine-derived phospholipids, phosphatidic acids and eicosanoids. All of these are formed acutely in immune cells through the actions of phospholipases and other enzymes, for example, phospholipase A 2 (PLA 2 ), that hydrolyzes phospholipids at sn2, generating fatty acid substrates for oxidation by cyclooxygenases (COX) and lipoxygenases (LOX) 7, 8 . Thus, acute activation of innate immune cells and platelets results in significant remodeling of the lipid compartment. However, how this is organized on a molecular and cellular level, particularly in terms of membrane lipid composition and biophysics is not well understood.
One group of phospholipid signaling mediators that has been extensively studied in recent years is oxidized phospholipids, generated through non-enzymatic redox cycling reactions that occur in chronic inflammation and atherosclerosis. Hundreds of species are known to form, with only a select few analyzed for structure and function to date (reviewed in 9 ). Early studies on these lipids focused on characterizing the biological action of airoxidized phosphatidylcholine (PC) in vitro [9] [10] [11] . Later, investigators began to fractionate and focus on individual species, including 16:0-05:0(ALDO)-PC (POVPC), and 16:0- [12] [13] [14] . Since these lipids are generated through non-enzymatic reactions, their formation is considered to be uncontrolled and associated with later stage disease, as opposed to a regulated event triggered during innate immune cell activation.
The advent of new generation benchtop mass spectrometers, coupled with high performance liquid chromatography (LC-MS/MS) has led to a significant resurgence in the study of lipids in health and disease [15] [16] [17] . Over the last 10 years, structural identification of low abundance phospholipid molecular species in limited amounts of highly complex cellular lipid extracts has become possible. This has revolutionized the field, with recent highlights including the mass spectrometry analysis of phosphoinositides in neutrophils, studies on the role of phosphatidylcholine metabolites in cardiovascular disease and detailed profiling of the plasma lipidome in humans [18] [19] [20] .
In this review, we focus on how LC-MS/MS has been used to uncover new families of enzymatically-oxidized phospholipids generated by activated human immune cells and platelets. These differ from the non-enzymatically oxidized phospholipids described above, since they comprise a small number of specific molecular species, and they are formed acutely on immune cell activation. We describe the identification and characterization of these new lipid species, followed by what is known regarding their in vivo generation and biological functions. Lastly, we describe how recently-developed high-resolution rapidscanning instruments offer significant new possibilities in terms of powerful approaches that aim to discover new structures, and have the potential to redefine how we study the biology and biochemistry of lipid mediators in the immune system.
Early studies on esterified eicosanoid generation by immune cells.
During immune cell activation, phospholipase A 2 (PLA 2 ) hydrolysis of phospholipids releases free arachidonate, which is oxidized by lipoxygenase (LOX), cyclooxygenase [24] [25] [26] . However, it has since become clear that incorporation of exogenous HETEs into membranes is very different to the fate of endogenously-generated eicosanoids formed via oxidation of cellular substrate, and so this will not be further discussed in this review.
In 2005, Marnett and co-workers demonstrated the cellular generation of esterified prostaglandins for the first time, including both PGE 2 and PGD 2 attached to glycerol and ethanolamine [27] [28] [29] . These lipids were initially identified in vitro, generated using purified COX-2, but then subsequently in murine macrophages with endogenous substrate.
Shortly after, while investigating the cell biology of 15-LOX, we also noted that significant 15-HETE was acutely generated as esterified products by interleukin-4-treated human monocytes. To determine the molecular species to which this was attached, a targeted lipidomic approach was developed that utilized precursor scanning LC-MS/MS to "fish" for lipids that contained a HETE functional group. These studies led to the discovery of several additional families of phospholipid-esterified eicosanoids, and are described in . However we note that HETE-PEs are poorly incorporated by leukocytes, with only 5 -10 % becoming cell-associated over 24 hrs (unpublished data). Thus, added amounts will be much lower than that ultimately present in the cells, and can be considered biologically-relevant. Also, exogenously added lipid will be present in the supernatant primarily, rather than cell associated, as for endogenous HETE-PE. Overall, these signaling actions suggest that HETE-PEs generated by monocyte/macrophage 12/15-LOX display anti-inflammatory bioactivities. This is 
Generation of esterified eicosanoids by neutrophils.
Neutrophils express a 5-LOX isoform that is activated by several agonists including bacterial peptides, chemokines and chemical stimuli such phorbol and calcium ionophore.
The primary 5-LOX product, 5-HpETE, is the precursor for leukotriene synthesis, or can be converted by glutathione peroxidases (GPX) to the more stable 5-HETE, which in turn can be oxidized to the potent chemoattractant, 5-oxo-ETE
46
.
We conducted precursor scanning of lipid extracts from ionophore-activated human neutrophils and detected four molecular species, that were subsequently identified as one HETE-PC ( 5-HETE-PEs were detected in both human and murine peritonitis, co-inciding with the timepoint of maximum neutrophil influx 47 . Stimulation of their generation in vitro by live bacteria requires opsonization, indicating that complement or antibody is likely to be involved. Highest levels were found with gram-positive infection, as expected since neutrophil influx was greatest in these patients 47 .
5-HETE-PEs regulate a number of neutrophil activities in vitro, including enhancing superoxide and IL-8 release, and inhibiting neutrophil extracellular trap (NET) release 47 .
These biological actions were demonstrated at around 7.8 μg added 5-HETE-PE per 10 6 cells, while in contrast neutrophils synthesize around 400 ng/10 6 cells 47 . However, as described earlier, exogenously added HETE-PEs are poorly incorporated by primary leukocytes, while almost all that is endogenously-generated is retained 47, and unpublished data .
In support of the idea that 5-HETE-PEs mediate these actions when endogenously generated, we found that two pharmacologically-distinct 5-LOX inhibitors (MK886 and zileuton) both enhanced NET generation in vitro 
Generation of esterified eicosanoids by human platelets.
Platelets express two eicosanoid generating enzymes, a platelet-specific 12-LOX and cyclooxygenase-1 (COX Figure 1B ,E).
12S-HETE was the prominent enantiomer, indicating the requirement for 12-LOX 52 .
Furthermore, they are absent in platelets from 12-LOX -/-mice (Aldrovandi et al, unpublished). The lipids are generated within 5 min, and levels continue to increase slowly up to 30 min after activation. Esterified HETEs account for up to a quarter of the total 12-HETE generated, and as for other cells, they remain cell associated. In resting cells, PE is predominantly facing the cytosol, but along with phosphatidylserine (PS), is externalized on cell activation. This is in contrast to PC which predominantly comprises the outer leaflet. We found that a small amount of 12-HETE-PE becomes externalized following its synthesis 52 . This suggests that oxidized phospholipids may regulate extracellular phospholipid-dependent signaling events. One important process that requires the presence of negatively-charged PE and PS on the cell surface is coagulation. In this, several clotting factors become active through proteolytic cleavage in response to injury (release of tissue factor), associate with the plasma membrane, and generate thrombin.
Coagulation factor activity can be tested in vitro by activating the cascade in human
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From plasma using exogenous tissue factor, in the presence of liposomes of varying composition. Using this assay, we found that HETE-PC dose-dependently stimulates tissue factor-dependent thrombin generation at concentrations found in human platelets 52 .
This is consistent with previous reports showing that non-enzymatically oxidized lipid can enhance coagulation, suggests a role for the lipids in promoting hemostasis 53, 54 . As this is currently a preliminary finding, and its biological relevance is not yet known, the mechanisms involved are currently being explored using recombinant coagulation factors, in vitro. 
New generation mass spectrometry approaches for identification of immune cell lipids.
The identification of esterified eicosanoids described in this review utilized a mass spectrometry method termed precursor scanning that takes advantage of the facile fragmentation of these species to generate a characteristic eicosanoid carboxylate anion on collision-induced-dissociation. This mode is available on standard triple quadrupole instruments, and when combined with an ion trap (e.g. Q-Trap), enables MS/MS to also be performed during elution, greatly aiding structural identification. Using this mode, lipid extracts were analyzed for families of lipids that contain a common functional group, specifically, an eicosanoid 39, 40, 47, 52, 55 . Since the mass spectrometry fragmentation patterns of both eicosanoids and phospholipids are already well known, the structural characterization of these lipids was quite straightforward. This approach could equally be used for lipids containing other functional groups of interest, e.g. particular fatty acids or short chain modified lipids where the fragment generates a negative ion. Where a charged species is not formed on dissociation, neutral loss scanning can alternatively be used. Our methods coupled precursor scanning to high pressure liquid chromatography. Good separation is essential for analysis of complex lipid extracts, since artifactual adducts of HETEs with other matrix constituents can form in the electrospray source that behave similar to esterified HETEs, when direct infusion of complex lipid extracts is performed. In our studies, an extraction method that extracts most lipid species was utilized, where cells or tissue (homogenized in the presence of antioxidants and metal chelators) is vortexed Another recently described approach involved derivatization of the PE headgroup using isotope-labeled 4-(dimethyamino)benzoic acid (DMABA) 56 . Generally, selective detection of PE by MS relies on neutral loss of m/z 141. However, this scan does not allow detection of plasmalogen species. Headgroup derivatization by DMABA enables all subclasses of PE to be detected by a common precursor ion scan in positive mode, while also allowing detection in negative ion mode for CID, with identification of radyl groups 57 .
Modification of this approach, where control lipids and 2,2'-azobis-(2-amidinopropane)
hydrochloride lipid extracts from RAW264.7 cells were derivatized using d0-DMABA or d6-DMABA respectively, allowed identification of several oxidized PEs including truncated structures 56 .
Precursor scanning works only for lipid families where part of the structure is already known. More recently, we have begun to utilize high resolution rapid scanning, Esterified eicosanoids are closely related to non-enzymatically oxidized phospholipids, that comprise >100's of molecules originally identified during air or chemical oxidation of unsaturated phospholipids in vitro (for review see 9 ). Indeed, the molecular structures described herein that originate from LOX or COX turnover, will also be present at low concentrations in non-enzymatically-generated mixtures. The key difference is that enzymes generate a restricted number of specific products, with oxygen insertion effectively dictated by the enzyme pathway involved. Non-enzymatically oxidized phospholipids display pleiotropic biological actions, including some that are common to the lipids described herein, such as modulation of TLR and PPARγ signaling (reviewed in 9 ).
Non-enzymatically oxidized phospholipids that originate from decomposition of phospholipid hydroperoxides have been measured in inflammation and atheroma (reviewed in   9 ). However, while the decomposition itself is likely to be uncontrolled, whether the primary hydroperoxides originate from enzymatic or non-enzymatic oxidation in vivo is not clear. An important difference in the processes that generate these two lipid classes is that enzymatically generated oxidized phospholipids are formed through controlled processes involving receptors and intracellular signaling pathways, using enzymes that are conserved among all mammalian species. This indicates that these lipids are of physiological relevance, and likely to be important in innate immune events including hemostasis and bacterial killing. In contrast, non-enzymatic oxidized phospholipids will be generated during chronic inflammation and atherosclerosis, through redox cycling of metals or uncontrolled oxidant toxicity. In both cases, common bioactivities are displayed, although in chronic disease these processes will be occurring in an inappropriate and uncontrolled manner that contributes to the disease, rather than being required for maintenance of health and homeostasis. Thus, both are of importance in human health and disease, but the relative contribution of signaling will depend on the inflammatory context and the types and amounts of each species generated.
In summary, we describe several new families of enzymatically oxidized phospholipids formed by acutely activated cells. Their generation and retention in the cell occurs in concert with profound changes in plasma membrane function. Thus, future work will determine how the lipids regulate membrane behavior at local level, in particular changes in shape and form such as occurring during phagocytosis, aggregation, microparticle release and chemotaxis. 
